South Korea Next-Generation Sequencing Market

The report "South Korea Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing (Consumables), Platforms, Bioinformatics), Application (Drug Discovery, Diagnostic, Agriculture) - Forecast to 2031 ", is projected to USD 386.3 million by 2031 from USD 201.0 million in 2026, at a CAGR of 14.0% during the forecast period.

Browse 250 market data Tables and 40 Figures spread through 200 Pages and in-depth TOC on "South Korea Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing (Consumables), Platforms, Bioinformatics), Application (Drug Discovery, Diagnostic, Agriculture) - Forecast to 2031 "
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/south-korea-next-generation-sequencing-market-42991854.html

Key drivers of growth in the South Korea next-generation sequencing (NGS) market include declining cost of sequencing and advancements in bioinformatics, substantial government investment initiatives and the increasing demand for advanced sequencing technologies. The South Korean government has announced significant investment aimed at developing cutting-edge NGS platforms and data analysis tools. The declining cost of sequencing and advancements in bioinformatics are making sequencing technologies more accessible. The push for precision medicine and bespoke treatments is catalyzing demand for NGS technologies, driven by genomic analysis projects. Collaboration with international technology partners is enhancing South Korea's capabilities in genome analysis. Partnerships with governmental agencies and strategic investments in genomic research and healthcare infrastructure are further supporting market expansion.

The diagnostics application is expected to account for significant growth in the South Korea next-generation sequencing market during the forecast period.

Diagnostic applications are expected to exhibit robust growth during the forecast period with a CAGR of 14.4%. The demand for NGS in diagnostics is driven by the need for precision medicine and genomic analysis in healthcare. With the rise of personalized treatment approaches, healthcare providers face significant opportunities in utilizing genomic data to improve patient outcomes. By implementing NGS-based diagnostic solutions, healthcare institutions can establish reliable systems for identifying genetic variations and supporting clinical decision-making. The technology enables comprehensive analysis of genetic information, supporting early disease detection and targeted therapeutic interventions.

The consumables segment is projected to account for a significant share of the South Korea next-generation sequencing market.

Consumables represent a critical component of NGS workflows and include reagents, kits, and other materials required for sequencing operations. These products are essential for the preparation, processing, and analysis of genetic samples. The consumables segment supports various stages of the sequencing process, from sample preparation through data generation. They are designed to ensure accuracy, reliability, and reproducibility of sequencing results. Consumables are used across multiple applications, including diagnostics, drug discovery, and research. The recurring nature of consumable purchases and their essential role in NGS operations contribute to their significant market share. Owing to these characteristics, consumables are expected to contribute a major share of the market.

South Korea is expected to register significant growth during the forecast period.

Growing pharmaceutical, biotechnology, and research applications in South Korea are expected to drive the next-generation sequencing market. The country is focusing on developing and adopting advanced sequencing solutions through targeted government partnerships and investments in local infrastructure. Strategic investments in genomic research and healthcare infrastructure are boosting market development. South Korea is becoming an attractive destination for NGS research, with international companies expanding their presence in the Asia Pacific region. This expansion creates opportunities for enhanced genomic capabilities and strengthened research infrastructure to meet rising demand during the forecast period.

The report profiles key players such as Illumina Inc. (US), Thermo Fisher Scientific Inc. (US), QIAGEN (Netherlands), PacBio (US), and Oxford Nanopore Technologies plc. (UK).

Don’t miss out on business opportunities in South Korea Next-Generation Sequencing Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/